Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs S&P500 ETF (SPY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs S&P500 ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while S&P500 ETF trades at $767.04 (market cap $823.23B). The key difference: S&P500 ETF is far larger — about 26.6× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while S&P500 ETF pays none. Which is the better fit depends on your goals.
| GEHC | SPY | |
|---|---|---|
Market Cap | $30.93B | $823.23B |
Volume | 5,033,451 | 55,376,546 |
Sector | Health | — |
52-Week High | $88.16 | $779.14 |
52-Week Low | $59.48 | $631.99 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 206 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SPY (SPDR S&P 500 ETF) trades at $778.05, showing minimal daily movement with a slight decline of 0.02%. Technical indicators signal a bullish trend with moving averages strongly supporting upward momentum, though oscillators remain neutral. The ETF maintains key support at $777 and resistance at $779. Recent news highlights S&P 500 valuation debates and sector rotations, with earnings growth expectations moderating from 35% in 2026 to 15% in 2027 according to Wall Street analysts.
The outlook for SPY remains positive given its broad market exposure and institutional support, though investors face risks from potential market volatility and slowing earnings growth. Current technical strength suggests near-term stability, but macroeconomic factors and sector-specific challenges could impact performance. The ETF's diversification provides resilience, but market-wide valuation concerns warrant cautious optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →
